How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum
暂无分享,去创建一个
[1] A. Grace,et al. Aversive Stimuli Alter Ventral Tegmental Area Dopamine Neuron Activity via a Common Action in the Ventral Hippocampus , 2011, The Journal of Neuroscience.
[2] Habib Zaidi,et al. PET versus SPECT: strengths, limitations and challenges , 2008, Nuclear medicine communications.
[3] Kirsten A. Porter-Stransky,et al. Development of behavioral preferences for the optimal choice following unexpected reward omission is mediated by a reduction of D2‐like receptor tone in the nucleus accumbens , 2013, The European journal of neuroscience.
[4] Erwan Bezard,et al. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated , 2003, Trends in Neurosciences.
[5] C. Adler,et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.
[6] P. Garris,et al. ‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat , 2003, Journal of neurochemistry.
[7] P. Garris,et al. Real‐time decoding of dopamine concentration changes in the caudate–putamen during tonic and phasic firing , 2004, Journal of neurochemistry.
[8] O. Hikosaka. Basal Ganglia Mechanisms of Reward‐Oriented Eye Movement , 2007, Annals of the New York Academy of Sciences.
[9] H. Nijhout,et al. Passive and active stabilization of dopamine in the striatum , 2009 .
[10] Jakob K. Dreyer,et al. Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling. , 2013, Journal of neurophysiology.
[11] F. Fujiyama,et al. Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.
[12] M. Kassiou,et al. Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesions , 2006, Behavioural Brain Research.
[13] P. Garris,et al. Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism , 2011, Neuroscience.
[14] Sylvia M. L. Cox,et al. Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes , 2015, NeuroImage.
[15] T. Robinson,et al. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine‐induced rotation during. The first week following a unilateral 6‐OHDA lesion of the substantia nigra , 1994, Synapse.
[16] Nan Luo,et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times , 2010, Movement disorders : official journal of the Movement Disorder Society.
[17] J. Dreyer. Three Mechanisms by which Striatal Denervation Causes Breakdown of Dopamine Signaling , 2014, The Journal of Neuroscience.
[18] T. Padel,et al. A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion , 2015, Behavioural Brain Research.
[19] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[20] Rafael Luján,et al. Disruption of Dopamine Neuron Activity Pattern Regulation through Selective Expression of a Human KCNN3 Mutation , 2013, Neuron.
[21] P. Greengard,et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] U. Ungerstedt,et al. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. , 1970, Brain research.
[23] A. Grace,et al. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission , 2003, Nature Neuroscience.
[24] D. Surmeier,et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons , 2007, Trends in Neurosciences.
[25] S. Dunnett,et al. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites , 2012, Behavioural Brain Research.
[26] Rune W. Berg,et al. Influence of Phasic and Tonic Dopamine Release on Receptor Activation , 2010, The Journal of Neuroscience.
[27] Terry Kenakin,et al. New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2 , 2013, British journal of pharmacology.
[28] D. Sulzer,et al. How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.
[29] A. Grace,et al. The control of firing pattern in nigral dopamine neurons: single spike firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] David P. Daberkow,et al. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum , 2011, Journal of neurochemistry.
[31] A. Grace,et al. The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] S. Lewis,et al. Modern therapeutic approaches in Parkinson's disease , 2003, Expert Reviews in Molecular Medicine.
[33] P. Garris,et al. Phasic‐like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine‐induced partial dopamine denervation , 2013, Journal of neurochemistry.
[34] P. Christophersen,et al. Pharmacological modulation of the gating properties of small conductance Ca2+-activated K+ channels alters the firing pattern of dopamine neurons in vivo. , 2010, Journal of neurophysiology.
[35] V. Lovic,et al. Functionally Distinct Dopamine Signals in Nucleus Accumbens Core and Shell in the Freely Moving Rat , 2016, The Journal of Neuroscience.
[36] E. Castañeda,et al. Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior , 2009, Behavioural Brain Research.
[37] C. Gerfen. Molecular effects of dopamine on striatal-projection pathways , 2000, Trends in Neurosciences.
[38] Anatol C. Kreitzer,et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry , 2010, Nature.
[39] J. Obeso,et al. How does Parkinson's disease begin? The role of compensatory mechanisms , 2004, Trends in Neurosciences.
[40] C. Gerfen,et al. D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Animal Model of Parkinson’s Disease , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[41] I. Liste,et al. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression , 1996, Experimental Brain Research.
[42] Richard Wade-Martins,et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model , 2013, Proceedings of the National Academy of Sciences.
[43] L. Regeur,et al. Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[44] E. Pothos,et al. Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size , 1998, The Journal of Neuroscience.
[45] J. Girault,et al. Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol , 2008, The Journal of Neuroscience.
[46] H. Bergman,et al. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease , 2014, Neurology.
[47] G. Turrigiano. Homeostatic signaling: the positive side of negative feedback , 2007, Current Opinion in Neurobiology.